Skip to main content
HairCited

Düşük Seviyeli Lazer Tedavisi için Kadın Tipi Saç Dökülmesi

A

8 çalışmaya (1 meta-analysis, 2 RCTs), toplam 5,391 katılımcıyla dayanmaktadır. 7/8 çalışma olumlu etkiler göstermektedir.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dlow\u002Dlevel\u002Dlaser\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Sonuç

Low-level laser therapy has strong evidence for female pattern hair loss and represents one of the best-supported non-medication options available for women experiencing this condition.

  • 7 out of 8 studies report positive effects, including well-designed RCTs with sham controls
  • Especially relevant for women who may want to avoid oral medications
  • Included in international clinical guidelines for female pattern hair loss
  • Both clinical treatments and at-home devices have shown effectiveness in studies

Key Study Findings

randomized controlled trial n=9 12.5 weeks Single-blind
Photobiomodulation therapy and 5% minoxidil in female pattern hair loss: a case series focusing on …
Dose: Photobiomodulation therapy (PBMt; red laser 100mW, 4J/point, 25 sessions, twice weekly) + minoxidil vs: Placebo Etki: Both groups improved QoL and hair density; PBMt + MIN showed significantly greater reduction in telo None
Randomized Controlled Trial 24 weeks Single-blind
Comparative efficacy of 2% minoxidil alone against combination of 2% minoxidil and low-level laser therapy …
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: None

Randomized Controlled Trial
Comparison of low-level light therapy and combination therapy of 5% minoxidil in the treatment of …
Dose: 3 g vs: control Outcome: None Etki: None P < 0.05

Popülasyon: None

prospective interventional study (single-arm) n=20 16 weeks
Results of low-level laser therapy in the treatment of hair growth: An Egyptian experience.
Dose: 20 minutes, 2 sessions/week for 16 weeks (32 total sessions) vs: Placebo Etki: FPHL: 222.3 to 255.3 hairs/cm² (p=0.007); TE: 271.2 to 294.2 hairs/cm² (p=0.143) 0.007 (FPHL); 0.143 (TE)
Review
Female pattern hair loss: A comprehensive review.
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: Female pattern hair loss patients

Review 16 weeks
Examining the Safety and Efficacy of Low-Level Laser Therapy for Male and Female Pattern Hair …
Dose: Low-level laser therapy (LLLT), 600-1100 nm wavelength, treatment ≥16 weeks vs: Placebo Etki: All 8 sham-controlled studies showed statistically significant increase in hair diameter or density p < 0.01 (all sham-device cont

Key Statistics

14

Çalışmalar

5537

Katılımcılar

Positive

A

Derece

Referenced Papers

Dermatologic therapy 2020 48 atıf
The Cochrane database … 2016 18 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

hairloss:
8-15 minutes, 3x/week

Üst sınır: Not applicable

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
Photobiomodulation therapy (PBMt; red laser 100mW, 4J/point, 25 sessions, twice weekly) + minoxidil 12.5 weeks Positive 9
None 24 weeks Positive --
3 g -- Positive --
20 minutes, 2 sessions/week for 16 weeks (32 total sessions) 16 weeks Positive 20
None -- Negative --
Low-level laser therapy (LLLT), 600-1100 nm wavelength, treatment ≥16 weeks 16 weeks Positive --
finasteride 1 mg/d, dutasteride 0.5 mg/d, topical minoxidil 5% twice daily (MPHL); topical minoxidil -- Positive --
None -- Mixed --

En iyi alım zamanı: Use device for recommended duration 3 times per week on non-consecutive days

Safety & Side Effects

Bildirilen Yan Etkiler

  • Mild scalp warmth or tingling
  • Headache (uncommon)
  • Initial shedding phase (rare)
  • Dry scalp

Bilinen Etkileşimler

  • Photosensitizing medications (tetracyclines, fluoroquinolones) may increase scalp sensitivity
  • No significant interactions with oral hair loss medications

Tolere edilebilir üst alım: Not applicable

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Düşük Seviyeli Lazer Tedavisi help with Kadın Tipi Saç Dökülmesi?
Based on 14 studies with 5,537 participants, there is strong evidence from multiple clinical trials that Düşük Seviyeli Lazer Tedavisi may support Kadın Tipi Saç Dökülmesi management. Our evidence grade is A (Strong Evidence).
How much Düşük Seviyeli Lazer Tedavisi should I take for Kadın Tipi Saç Dökülmesi?
Studies have used various dosages. A commonly studied range is 8-15 minutes, 3x/week. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Düşük Seviyeli Lazer Tedavisi?
Reported side effects may include Mild scalp warmth or tingling, Headache (uncommon), Initial shedding phase (rare), Dry scalp. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Düşük Seviyeli Lazer Tedavisi and Kadın Tipi Saç Dökülmesi?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 14 peer-reviewed studies with 5,537 total participants. The overall direction of effect is positive.

Related Evidence

Şu durum için diğer içerikler: Kadın Tipi Saç Dökülmesi

Düşük Seviyeli Lazer Tedavisi diğer sağlık durumları için

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.